To support the management of patients with pulmonary arterial hypertension (PAH), Janssen is providing the following educational resources for you to operationalize risk assessment into your organization's daily practice, including:
- The Care4Today® app and Care4Today® Care Portal for you and your patients to support active engagement in PAH care
- REVEAL 2.0 and REVEAL Lite 2 resources for structured risk assessment
- Epic® and Cerner® EHR System Build Guides to help you calculate REVEAL 2.0 and REVEAL Lite 2 risk scores within your EHR
Importance of Risk Assessment in PAH
Learn why objective risk assessment matters in patients with PAHSee the Data
REVEAL 2.0 and REVEAL Lite 2 Risk Assessments
See how structured REVEAL 2.0 and REVEAL Lite 2 risk assessments can be incorporated into your practiceLearn More
EHR System Build Guides
Calculate REVEAL 2.0 and REVEAL Lite 2 risk scores within your Epic® or Cerner® EHR systemDownload Guides
Risk Assessment Resources
Explore risk assessment resources for you and your patientsDownload Resources
Building on 20 Years of PAH Innovation
Janssen is leading the way to building a brighter future in PAH. We are committed to strengthening our future legacy and extending our expertise to transform PAH into a chronic, manageable condition. By working to advance the science through ongoing research, such as sponsoring and funding the REVEAL Registry, we are expanding the scientific knowledge of PAH.
Through our educational resources, we want to continue empowering healthcare providers and patients to remain actively engaged in managing and tracking PAH.